MA45048A - Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one - Google Patents

Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one

Info

Publication number
MA45048A
MA45048A MA045048A MA45048A MA45048A MA 45048 A MA45048 A MA 45048A MA 045048 A MA045048 A MA 045048A MA 45048 A MA45048 A MA 45048A MA 45048 A MA45048 A MA 45048A
Authority
MA
Morocco
Prior art keywords
pyrrolo
pyrimidin
new derivative
derivative
new
Prior art date
Application number
MA045048A
Other languages
English (en)
Inventor
Naoki EGASHIRA
Koji Ichikawa
Yu KOBAYAKAWA
Takumitsu Machida
Toshihiro Sakamoto
Tetsuya Sugimoto
Fuyuki Yamamoto
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA45048A publication Critical patent/MA45048A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA045048A 2016-05-20 2017-05-19 Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one MA45048A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016101599 2016-05-20

Publications (1)

Publication Number Publication Date
MA45048A true MA45048A (fr) 2019-03-27

Family

ID=60325930

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045048A MA45048A (fr) 2016-05-20 2017-05-19 Nouveau dérivé de 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one

Country Status (22)

Country Link
US (1) US10538528B2 (fr)
EP (1) EP3459953B1 (fr)
JP (1) JP6576553B2 (fr)
KR (1) KR102149734B1 (fr)
CN (1) CN109153681B (fr)
AU (1) AU2017265769B9 (fr)
BR (1) BR112018073721B1 (fr)
CA (1) CA3024831C (fr)
DK (1) DK3459953T3 (fr)
ES (1) ES2882018T3 (fr)
HK (1) HK1259613A1 (fr)
HU (1) HUE055846T2 (fr)
MA (1) MA45048A (fr)
MX (1) MX2018014022A (fr)
MY (1) MY185962A (fr)
PH (1) PH12018502411A1 (fr)
PL (1) PL3459953T3 (fr)
PT (1) PT3459953T (fr)
RU (1) RU2713181C1 (fr)
SG (1) SG11201810360YA (fr)
TW (2) TWI732187B (fr)
WO (1) WO2017200087A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240089357A (ko) * 2021-10-13 2024-06-20 다이호야쿠힌고교 가부시키가이샤 조절장애 mapk 및/또는 pi3k 경로를 갖는 암을 갖는 대상체를 위한 치료 방법
WO2023143424A1 (fr) * 2022-01-27 2023-08-03 四川海思科制药有限公司 Dérivé azacyclique et son application médicale
WO2024009977A1 (fr) * 2022-07-05 2024-01-11 大鵬薬品工業株式会社 5h-pyrrolo[2,3-d]pyrimidine-6(7h)-one, et cristaux de sel de celui-ci
CN115850244B (zh) * 2023-02-24 2023-05-16 成都大学 一种托吡司他的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005249380C1 (en) * 2004-04-23 2012-09-20 Exelixis, Inc. Kinase modulators and methods of use
GB0608184D0 (en) * 2006-04-25 2006-06-07 Astex Therapeutics Ltd Pharmaceutical compounds
AR064416A1 (es) * 2006-12-21 2009-04-01 Cancer Rec Tech Ltd Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas.
US8915177B2 (en) * 2008-08-08 2014-12-23 Nestec S.A. Beverage machine with carrying handle and configurable appearance and side functions
AR074072A1 (es) * 2008-11-11 2010-12-22 Lilly Co Eli Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme
AU2010310786B2 (en) * 2009-10-23 2014-03-27 Eli Lilly And Company AKT inhibitors
BR112015021324A2 (pt) * 2013-03-11 2017-07-18 Merck Patent Gmbh derivados de 6-[4-(1h-imidazol-2-il)piperidin-1-il]pirimidin-4-amina como moduladores de atividade de quinase
JP6398659B2 (ja) 2014-11-28 2018-10-03 アイシン・エィ・ダブリュ株式会社 歯形部品の製造方法および歯形部品製造装置

Also Published As

Publication number Publication date
EP3459953B1 (fr) 2021-06-30
WO2017200087A1 (fr) 2017-11-23
PH12018502411A1 (en) 2019-09-16
RU2713181C1 (ru) 2020-02-04
TWI679202B (zh) 2019-12-11
US10538528B2 (en) 2020-01-21
TWI732187B (zh) 2021-07-01
AU2017265769B2 (en) 2019-05-02
HUE055846T2 (hu) 2021-12-28
HK1259613A1 (zh) 2019-12-06
BR112018073721B1 (pt) 2023-12-05
CN109153681B (zh) 2021-06-04
AU2017265769B9 (en) 2019-05-30
CN109153681A (zh) 2019-01-04
TW201920187A (zh) 2019-06-01
PT3459953T (pt) 2021-07-29
CA3024831C (fr) 2021-06-08
SG11201810360YA (en) 2018-12-28
EP3459953A4 (fr) 2020-01-08
MX2018014022A (es) 2019-04-04
US20190292190A1 (en) 2019-09-26
JP6576553B2 (ja) 2019-09-18
PL3459953T3 (pl) 2021-11-22
EP3459953A1 (fr) 2019-03-27
TW201742867A (zh) 2017-12-16
ES2882018T3 (es) 2021-11-30
DK3459953T3 (da) 2021-08-23
CA3024831A1 (fr) 2017-11-23
MY185962A (en) 2021-06-14
KR20180120777A (ko) 2018-11-06
JPWO2017200087A1 (ja) 2018-12-27
AU2017265769A1 (en) 2018-11-29
KR102149734B1 (ko) 2020-08-31
BR112018073721A2 (pt) 2019-02-26

Similar Documents

Publication Publication Date Title
ES2975767T3 (es) Derivados de pirrolo [1,2-b]piridazina
DK3478682T3 (da) [1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
HK1245764A1 (zh) 3-取代的5-氨基-6h-噻唑並[4,5-d]嘧啶-2,7-二酮化合物
MA53675A (fr) Composés substitués de pyrazolo[1,5-a]pyridine en tant qu'inhibiteurs de la kinase ret
HK1252752A1 (zh) 新型吡唑並嘧啶衍生物
IL243092A0 (en) New triazolo[d–4,5]pyrimidine histories
IL291597A (en) Selective sulfonation of benzodiazepine derivatives
HK1259613A1 (zh) 新型5h-吡咯並[2,3-d]嘧啶-6(7h)-酮衍生物
DK3177627T3 (da) Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-on-derivater med pde1-hæmmende aktivitet
ZA201605666B (en) Pyrazolo[1,5-a]pyrimidines as antiviral compounds
HK1254651A1 (zh) 吡唑並[1,5-a]嘧啶-3-甲酰胺的環醚衍生物
GB201522532D0 (en) Novel pyrrolo[3,2-c]pyridine-6-amino derivatives
ZA201902828B (en) Crystal of pyrido[3, 4-d]pyrimidine derivative or solvate thereof
MA46463A (fr) Composés de pyrazolo[1,5-a]pyridine substitués en tant qu'inhibiteurs de la kinase ret
TH1601001194A (th) อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่
TH1401007032A (th) การสังเคราะห์ไพร์โรโล [2,3-b] ไพริดีน